(Source: Florida Atlantic University) - At 79, Alfred Zara became a human research subject. His motivation: Stay in the driver's seat as long as possible.
"If I were curbed, that would be the end of my golden years," Zara said.
Certain that he has the beginning stages of Alzheimer's disease, Zara joined a clinical drug trial at Florida Atlantic University. Designed by Dr. Peter Holland, the trial is the only one of its kind in the United States. Through this research study, Holland hopes to find evidence that the drug Namenda can help preserve driving skills in patients with mild symptoms of Alzheimer's.